Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from FDA

Regeneron's Pipeline Hit By Catalent Delays, But Dupixent Shines

On Friday, Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) reported second-quarter adjusted earnings of $12.89 per share, up 12% year-over-year, beating the consensus of $8.57.

Benzinga

Moderna's Key Patent Win Overshadowed By Gloomy Outlook

Moderna Inc. (NASDAQ:MRNA) reported on Friday a second-quarter loss of $2.13 per share, beating the consensus of a $2.98 loss, an improvement from a loss of $3.33 a year ago.

Benzinga

Should You Buy the Post-Earnings Plunge in Novo Nordisk Stock or Stay Far, Far Away?

Novo Nordisk is a healthcare stock that is down 50% in 2025. Is NVO stock undervalued at current levels or can it move lower over the next 12 months?

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Lyme Disease Explained: Hidden Symptoms, and Why Justin Timberlake Is Sounding the Alarm

Justin Timberlake's health battle highlights the hidden symptoms of Lyme disease amid a sharp rise in 2025 US cases

International Business Times UK

10 Food Packaging Lies That Make You Overeat

Food manufacturers are masters of psychology, using clever language and design on their packaging to make products seem healthier than they are. This marketing technique, known as creating a “health halo,” tricks our brains into giving a food item a pass. We feel less guilty about consuming it, which often…

Grocery Coupon Guide

‘Progressive leftist saboteur’: How Laura Loomer’s single-handely got Donald Trump’s choice fired

Loomer's latest victory.

We Got This Covered

Vodka seltzers mislabeled as energy drinks trigger product recall

Packaging mixup resulted in drinks labeled as Celsius energy drinks actually containing High Noon vodka seltzers

The Guardian - US

Read news from The Economist, FT, and more,
with one subscription

How FDA panelists casting doubt on antidepressant use during pregnancy could lead to devastating outcomes for mothers

At a meeting held by the Food and Drug Administration on July 21, 2025, a panel convened by the agency cast doubt on the safety of antidepressant medications called selective serotonin reuptake inhibitors, or SSRIs, in pregnancy.

The Conversation

Moderna Announces 10% Workforce Cut Amid Declining COVID-19 Vaccine Sales, Regulatory Hurdles

Moderna Inc. (NASDAQ:MRNA) has announced plans to reduce its global workforce by approximately 10% by the end of the year due to decreasing COVID-19 vaccine sales and market uncertainty.

Benzinga

Celcius Energy Drink Lawsuit Coming? FDA Recalls Product For Traces Of 'Alcohol'

A vodka seltzer mix-up in Celsius cans prompts an FDA-backed recall and legal scrutiny, raising concerns about branding, safety, and supply chain accountability.

International Business Times UK

Celsius Energy Drink Cans Mislabeled With Vodka Triggers Recall And FDA Warning: What's Going On?

An unspecified number of cans labeled as Celsius Holdings Inc. (NASDAQ:CELH) energy drinks were accidentally filled with High Noon vodka seltzer before reaching stores, prompting a recall posted to the Food and Drug Administration's website.

Benzinga

Vinay Prasad vs the FDA: How One Doctor's Policies Collided with Politics and Cost Him His Job

Vinay Prasad resigns from the FDA after backlash over vaccine restrictions and gene therapy decisions. Political pressure cited in sudden departure.

International Business Times UK

To prevent 'unintentional alcohol ingestion,' High Noon is recalling vodka seltzers mislabeled as Celsius energy drinks

High Noon withdraws, partner.

Fortune

FDA looking to make vapes less addictive as agency head claims 85% of those sold are ‘illegal’

FDA Commissioner Marty Makary warns ‘epidemic’ of e-cigarette use in high schools needs to be tackled

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

What's Going On With Sarepta, Capricor And Other Gene Therapy Stocks On Wednesday?

In May, FDA Commissioner Marty Makary named Vinay Prasad the next director of the U.S. Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research (CBER). Within three months, Prasad resigned.

The Guardian - US

FDA’s top vaccine official leaves post after less than four months

Trump administration gives no details about reason for departure of Vinay Prasad, but he had critics and had taken unusual actions

Benzinga

GSK Lifts Outlook As Specialty Medicines, Vaccines Fuel Growth

British pharmaceutical giant GSK Plc (NYSE:GSK) shares rose on Wednesday after reporting second-quarter results that surpassed analyst expectations and led the company to raise its full-year 2025 guidance.

Barchart

2 Growth Stocks Wall Street Predicts Will Soar 74% to 159%

With a strong pipeline, these two biotechs are poised for explosive growth.

Get all your
news in one place.

100's of premium titles.
One news app.

The Mary Sue

‘Never drinking Dr Pepper again’: Worker gets sick after moving to new line at Dr Pepper plant. Now she’s warning soda lovers

A woman says that she’s blowing the whistle on a Dr Pepper plant after claiming to have experienced several health issues as a consequence of working for the company.

International Business Times

VALÉB Announces the Upcoming Launch of Groundbreaking Advancement in Cervical Pre-Cancer Treatment

VALÉB, a breakthrough cervical treatment device founded by Dr. Dirk Coeman, offers a safer, smoke-free, and fertility-friendly alternative to traditional LEEP and cone biopsies. Expected to launch in 2027, this innovation may transform reproductive care worldwide.

International Business Times

How Neuromodulation is Reshaping the Treatment of Resistant Mental Health Disorders and Restoring Hope

Michigan Advanced Psychiatry pioneers FDA-approved neuromodulation therapies like TMS, IV ketamine, and Spravato to treat resistant mental health conditions, offering fast, effective alternatives for patients who haven't responded to traditional care.

Barchart

1 Analyst Thinks This Former Pandemic Winner Could Surge 500% This Year

This risky biotech company faces significant challenges ahead. But it has already proven its worth and may be able to do so again.

Barchart

Up 215% YTD, Should You Grab This Growth Stock Before It’s Too Late?

If successful, Celcuity could emerge as one of the breakout biotech stars of 2025.

Saving Advice

These 7 Food Label Terms Are Meaningless, But Legally Allowed

You’ve seen them in every aisle: terms like “natural,” “made with whole grains,” or “no sugar added” plastered across food packages in bright, inviting fonts....

Benzinga

Sephience Gets FDA Approval, Now A Key Revenue Driver For PTC Therapeutics

The U.S. Food and Drug Administration approved on Monday PTC Therapeutics, Inc.’s (NASDAQ:PTCT) SEPHIENCE (sepiapterin) for children and adult patients with phenylketonuria (PKU).

1 … 64 65 66 67

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

the Food and Drug Administration

the Department of Health and Human Services

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.